tiprankstipranks
IntegraGen SA (FR:ALINT)
:ALINT
France Market

IntegraGen SA (ALINT) Price & Analysis

0 Followers

ALINT Stock Chart & Stats

€0.14
€0.00(0.00%)
At close: 4:00 PM EST
€0.14
€0.00(0.00%)

ALINT FAQ

What was IntegraGen SA’s price range in the past 12 months?
IntegraGen SA lowest stock price was €0.12 and its highest was €0.36 in the past 12 months.
    What is IntegraGen SA’s market cap?
    IntegraGen SA’s market cap is €1.24M.
      When is IntegraGen SA’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were IntegraGen SA’s earnings last quarter?
      Currently, no data Available
      Is IntegraGen SA overvalued?
      According to Wall Street analysts IntegraGen SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does IntegraGen SA pay dividends?
        IntegraGen SA does not currently pay dividends.
        What is IntegraGen SA’s EPS estimate?
        IntegraGen SA’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does IntegraGen SA have?
        IntegraGen SA has 6,727,332 shares outstanding.
          What happened to IntegraGen SA’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of IntegraGen SA?
          Currently, no hedge funds are holding shares in FR:ALINT
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            IntegraGen SA

            IntegraGen S.A. provides advanced human genome analysis services to academic researchers and life science businesses across France. Their comprehensive genomic offerings include transcriptomics, epigenomics, DNA sequencing, next-generation sequencing (NGS) specifically for cancer research, and SNP genotyping. The company also delivers clinical research solutions, such as clinical-grade sequencing and pharmacogenomic studies, in addition to supporting fundamental human genetic investigations. For agricultural applications, IntegraGen offers agrigenomic services covering crop and livestock genotyping, as well as high-throughput sequencing for these domains. Their microbial genomics division conducts whole-genome microbial sequencing and transcriptomics. IntegraGen further develops a suite of sophisticated bioinformatics tools: MERCURY is an online platform for oncology, designed to transform raw high-throughput sequencing data into molecular reports for translational and clinical research. SIRIUS, a cloud-based software, empowers researchers to analyze whole genome, whole exome, and gene panel sequencing information. Galileo is another cloud application that enables dynamic exploration of RNA-Seq expression data. Finally, GeCo, their genomic consulting service, provides researchers access to expert biostatisticians and bioanalysts. Founded in 2000 and headquartered in Évry, France, IntegraGen S.A. is a subsidiary of OncoDNA SA.

            IntegraGen SA (ALINT) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Nanobiotix
            Transgene
            GenSight Biologics SA
            Cellectis SA
            Hybrigenics SA Class A
            Popular Stocks